Artwork

Content provided by OIS Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by OIS Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ophthea's Transformative Shift, Clinical Successes, and Visionary Innovation

42:43
 
Share
 

Manage episode 384303520 series 2286865
Content provided by OIS Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by OIS Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Opthea, an Australian based biopharmaceutical company is dedicated to transforming retinal disease treatments and elevating patients' vision and quality of life. Join Firas Rahal, MD, in a captivating episode as he engages with Opthea's Founder and Chief Innovation Officer, Megan Baldwin, PhD.

Explore the compelling journey from oncology to ophthalmology, unraveling strategic decisions, navigating competitive landscapes, and achieving triumphs in clinical trials. Dr. Baldwin unfolds her remarkable career trajectory, from a PhD at the University of Melbourne to pivotal roles at Genentech and the Ludwig Institute for Cancer Research.

Tune in for exclusive insights, including:

  • Opthea's strategic approach to revolutionizing eye care
  • Clinical Trials: A deep dive into their success and impact
  • Comparison with Other Drugs: Differentiating factors and unique contributions
  • Future Directions: Exploring new horizons and clinical opportunities
  • Commercialization Timeline: Anticipated milestones and FDA approval strategies

Listen now for a compelling journey through Opthea's vision as they continue to shape the landscape of ophthalmological advancements.
Opthea: Opthea.com
Megan Baldwin, PhD: LinkedIn
Firas Rahal, MD ois.net/robert-rothman-md

  continue reading

402 episodes

Artwork
iconShare
 
Manage episode 384303520 series 2286865
Content provided by OIS Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by OIS Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Opthea, an Australian based biopharmaceutical company is dedicated to transforming retinal disease treatments and elevating patients' vision and quality of life. Join Firas Rahal, MD, in a captivating episode as he engages with Opthea's Founder and Chief Innovation Officer, Megan Baldwin, PhD.

Explore the compelling journey from oncology to ophthalmology, unraveling strategic decisions, navigating competitive landscapes, and achieving triumphs in clinical trials. Dr. Baldwin unfolds her remarkable career trajectory, from a PhD at the University of Melbourne to pivotal roles at Genentech and the Ludwig Institute for Cancer Research.

Tune in for exclusive insights, including:

  • Opthea's strategic approach to revolutionizing eye care
  • Clinical Trials: A deep dive into their success and impact
  • Comparison with Other Drugs: Differentiating factors and unique contributions
  • Future Directions: Exploring new horizons and clinical opportunities
  • Commercialization Timeline: Anticipated milestones and FDA approval strategies

Listen now for a compelling journey through Opthea's vision as they continue to shape the landscape of ophthalmological advancements.
Opthea: Opthea.com
Megan Baldwin, PhD: LinkedIn
Firas Rahal, MD ois.net/robert-rothman-md

  continue reading

402 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide